Search the Newsreel

Is Cleveland-Cliffs (NYSE:CLF) In Focus As Infrastructure Demand Lifts Steel?

Cleveland-Cliffs (NYSE:CLF) is gaining attention as an integrated iron ore and steel producer, prominent due to the rising demand from infrastructure and automotive sectors. The company's unique position in the domestic market, spanning from raw material extraction to finished steel products, makes it a …

Everest Group declares $2.00 per share dividend By Investing.com

Everest Group, Ltd. (NYSE:EG) announced that its Board of Directors declared a dividend of $2.00 per common share. This dividend is payable on or before September 25, 2026, to shareholders of record as of September 9, 2026. Everest Group operates globally in reinsurance and …

Everest Group Announces Dividend

HAMILTON, Bermuda, August 12, 2026--(BUSINESS WIRE)--Everest Group, Ltd. announced that its Board of Directors declared a dividend of $2.00 per common share. This dividend will be payable on or before September 25, 2026 to all shareholders of record as of September 09, 2026. About …

Earnings Flash (AVEX) AEVEX Corp. Reports Q2 Revenue $201.8M, vs. FactSet Est of $159.8M

AEVEX to Acquire BlackSea Technologies, Strengthening Its Multi‑Domain Autonomous Systems Capabilities

Acquisition to unite battle‑tested air, surface, and subsea autonomous platforms with scaled domestic manufacturing and a mission‑focused culture aligned to DoW priorities. SOLANA BEACH, Calif., August 12, 2026--(BUSINESS WIRE)--AEVEX Corp. (NYSE: AVEX), a leading U.S. defense technology company specializing in autonomous systems, AI‑enabled mission …

AEVEX Corp. Announces Financial Results for Second Quarter 2026

Enterprise value to revenue forward of Ever Glory United Holdings Limited – SGX:ZKX

China Everbright Water's Attributable Profit Down 8% in H1

Xilio Therapeutics (NASDAQ:XLO) Announces Earnings Results, Beats Estimates By $0.26 EPS

Xilio Therapeutics (NASDAQ:XLO) announced its earnings results, reporting an adjusted loss of $0.33 per share, which beat analyst estimates by $0.26. The company's revenue of $18.69 million also surpassed expectations, though Xilio Therapeutics remains unprofitable with a negative net margin. Despite institutional investor ownership …

Las acciones de Monster Beverage (MNST) parecen estar cerca de su valor razonable, mientras que los resultados ya se reflejan en el precio

BUA Foods, Unilever Selloffs Drag NGX Index, Investors Lose N1.8trn

The Nigerian Exchange (NGX) All-Share Index declined by 1.12%, causing investors to lose N1.8 trillion, primarily due to selloffs in BUA Foods and Unilever Nigeria Plc. Sustained profit-taking in mid-cap and blue-chip stocks like BUAFOODS and UNILEVER, along with the listing of additional shares …

Xilio Therapeutics Releases Q2 2026 Financial Results

Xilio Therapeutics (XLO) reported its Q2 2026 financial results, showing a narrower net loss of $0.33 per share, an 85.3% improvement year-over-year. Revenue significantly increased by 131.2% to $18.7 million compared to Q2 2025. The company specializes in tumor-activated immuno-oncology therapies and continues to …

Monster Beverage (MNST) Stock Looks Near Fair Value While Earnings Price In More

Monster Beverage (MNST) stock appears to be near fair value according to a Discounted Cash Flow (DCF) model, despite trading roughly 7.8% above the DCF estimate. However, earnings-based multiples suggest the stock is overvalued, with a P/E ratio of 41.9x compared to the industry …

UNILEVER AKTIE: AI-Analysen, Prognose & Kursziel

Goldman Sachs Group (TDAC) discloses 1,056,879 TDAC shares in 7.2% stake

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a beneficial ownership of 1,056,879 Class A ordinary shares in Translational Development Acquisition Corp. (TDAC), representing a 7.2% stake. Both entities hold shared voting and shared dispositive power over …

Achieve Life Sciences Stock Has Nearly Tripled in the Last Year. Now It Just Needs to Turn a Profit.

Pile of money with hands by Sergey Nazarov via iStock Achieve Life Sciences (ACHV) is a $685 million biotech focused on cytisinicline-based nicotine addiction treatments, showing strong recent technical momentum. ACHV has surged 173% over 52 weeks. Shares recently hit a 3-year high earlier …

DeFi Development Corp. Reports Q2 2026 Results, Grows SOL

DeFi Development Corp. (Nasdaq: DFDV) announced its Q2 2026 results, highlighting a 24% year-over-year growth in SOL per share (SPS) to 0.066 and a total of 2,311,523 SOL and equivalents. The company outlined Q3 cost efficiencies, capital structure simplification, and reaffirmed its long-term target …

All You Need to Know About Everforth (EFOR) Rating Upgrade to Strong Buy

Everforth (EFOR) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change. The Zacks rating …

Transcript : Peyto Exploration & Development Corp., Q2 2026 Earnings Call, Aug 12, 2026

Key Points Interested in Peyto Exploration & Development Corp.? Here are five stocks we like better. Q2 financial performance remained solid: Peyto generated C$228 million in funds from operations, reduced net debt by C$72 million and raised its monthly dividend by 9%, despite seasonal …

Why Are Everpure (P) Shares Soaring Today

Why Are Everpure (P) Shares Soaring Today What Happened? Shares of data storage solutions provider Everpure (NYSE:P) jumped 9.7% in the morning session after Susquehanna upgraded the stock to Positive from Neutral and raised its price target to $120 from $85. The firm pointed …

EVTC or MA: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Financial Transaction Services sector have probably already heard of Evertec (EVTC) and MasterCard (MA). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. There are plenty of …

Everest Group (NYSE:EG): Is Value Still Hiding In Plain Sight?

Everest Group (NYSE:EG) is facing renewed valuation scrutiny following a mixed quarterly update and a shelf registration for common stock. The company's softer revenue and net income trends are being weighed against its strong underwriting platform and global market position in insurance and reinsurance. …

EverCommerce (EVCM) Is Down 17.1% After Softer Outlook And CEO Change - Has The Bull Case Changed?

Jefferies says World Cup and stockpiling flattered Unilever's standout quarter

Jefferies has increased its price target for Unilever PLC to 3,900p, up from 3,800p, while maintaining an "underperform" rating. The analyst firm suggests that Unilever's strong second-quarter volume growth was artificially boosted by about 2 percentage points due to one-off factors like World Cup …

Is Evertec (EVTC) Outperforming Other Business Services Stocks This Year?

For those looking to find strong Business Services stocks, it is prudent to search for companies in the group that are outperforming their peers. Evertec (EVTC) is a stock that can certainly grab the attention of many investors, but do its recent returns compare …

New City Development Group Clarifies Board and Committee Structure

New City Development Names Li Yang Co-CEO in Leadership Reshuffle

Everspin Technologies Adds Vikas Choudhary to Board as AI Memory Demand Grows

Everspin Technologies (NASDAQ: MRAM) has appointed Vikas Choudhary to its board of directors, effective August 10, 2026. Choudhary, a semiconductor executive with over 30 years of experience, will help guide the company's efforts to expand the adoption of its MRAM technology in the growing …

Beverly Wilshire Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

AEVEX (AVEX) Corp brings 33.3% weekly rebound to Aug. 12 earnings

The aerospace and defense stock has recovered over four weeks, but weekly context remains mixed as the 12-week return is still negative.

Everspin appoints Vikas Choudhary to board of directors

Everspin Technologies, Inc. (NASDAQ:MRAM) has announced the appointment of Vikas Choudhary to its board of directors, effective August 10. Choudhary, currently a senior vice president at MaxLinear, brings extensive experience in business and product strategy within the data center, cloud network, and enterprise markets. …

Form 8K Xilio Therapeutics Inc For: 12 August By Investing.com

This article reports on Xilio Therapeutics Inc.'s Form 8K filing for August 12. It notes the company's stock symbol as XLO, which saw a -1.42% change. The content primarily serves as a placeholder or announcement regarding the SEC filing.

Monster Beverage achieves monster results

Monster Beverage Corp. reported record financial results in its second quarter, surpassing $2.5 billion in net sales for the first time, with double-digit sales growth across all geographic regions. The company's innovative product lineup, including the successful Ultra Red, White and Blue limited-time beverage …

Everbright Greentech interim net profit rises 2pc to HK$195.35m on cost controls

China Everbright Water (SGX:U9E) Can Margin Gains Recast Its Low P E Story?

Xilio Therapeutics reports Q2 2026: $18.7M collaboration revenue, $6.4M net loss, cash $136.0M

Xilio Therapeutics reported its Q2 2026 financial results, showing $18.7 million in collaboration revenue and a net loss of $6.4 million. The company held $136.0 million in cash and cash equivalents, expecting this to fund operations into Q1 2028. Key business highlights include FDA …